2018-2023 Global Anti-tumor Drug Market Report (Status and Outlook)
- LP 2661144
- 131 Pages
- August 2018
- Medical Devices
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, antitumor drugs are also the key areas of concern for many enterprises. Such as Jiangsu Hengrui, Qilu Pharmaceutical and other well-known domestic enterprises in the anti-tumor drugs have invested a lot of money, there are many innovative anti-cancer drugs into the clinical research stage. In the meantime, there has been "explosive" growth in the development of molecularly targeted drugs, with at least hundreds of drugs under development, and it is conceivable that the market will be quite crowded in the next five to 10 years. Therefore, domestic enterprises should fully understand the feasibility of the project and the fierce market competition that they may face in the future.
China's bio-pharmaceutical industry already has a good foundation; from the national level to local governments at all levels continue to step up efforts to support the development of bio-pharmaceutical industry. The output value of the pharmaceutical industry maintained a growth rate of 20% during the 12th Five-Year Plan period. In 2013, the total output value of the pharmaceutical industry reached 2.1 trillion yuan. However, compared with the bio-pharmaceutical industry in the advanced countries in the world, there is still a huge gap between the biomedical industry in our country and the demand for building an overall well-to-do society. Mainly manifested in: small-scale enterprises, more than 10 billion yuan enterprises and more than one billion yuan less; independent innovation ability is weak, many varieties of imitation with independent intellectual property rights of the few species; restrict some of the long-term development of biomedical industry , Deep-seated problems still exist.
Over the next five years, LPI(LP Information) projects that Anti-tumor Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Anti-tumor Drug market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Cytotoxic Drugs
Non-cytotoxic Drugs
Segmentation by application:
Alkylating Agents
Anti-metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline antitumor drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anti-tumor Drug market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Anti-tumor Drug market by identifying its various subsegments.
Focuses on the key global Anti-tumor Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-tumor Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Anti-tumor Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Anti-tumor Drug Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-tumor Drug Market Size 2013-2023
2.1.2 Anti-tumor Drug Market Size CAGR by Region
2.2 Anti-tumor Drug Segment by Type
2.2.1 Cytotoxic Drugs
2.2.2 Non-cytotoxic Drugs
2.3 Anti-tumor Drug Market Size by Type
2.3.1 Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
2.3.2 Global Anti-tumor Drug Market Size Growth Rate by Type (2013-2018)
2.4 Anti-tumor Drug Segment by Application
2.4.1 Alkylating Agents
2.4.2 Anti-metabolism Drugs
2.4.3 Platinum Antineoplastic Agents
2.4.4 Anthracycline antitumor drugs
2.4.5 Microtubule Stabilizer
2.4.6 Endocrine Therapy Drugs
2.4.7 Immunotherapy Drugs
2.4.8 Gene Therapy Drugs
2.4.9 Targeted Antineoplastic Drugs
2.5 Anti-tumor Drug Market Size by Application
2.5.1 Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
2.5.2 Global Anti-tumor Drug Market Size Growth Rate by Application (2013-2018)
3 Global Anti-tumor Drug by Players
3.1 Global Anti-tumor Drug Market Size Market Share by Players
3.1.1 Global Anti-tumor Drug Market Size by Players (2016-2018)
3.1.2 Global Anti-tumor Drug Market Size Market Share by Players (2016-2018)
3.2 Global Anti-tumor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-tumor Drug by Regions
4.1 Anti-tumor Drug Market Size by Regions
4.2 Americas Anti-tumor Drug Market Size Growth
4.3 APAC Anti-tumor Drug Market Size Growth
4.4 Europe Anti-tumor Drug Market Size Growth
4.5 Middle East & Africa Anti-tumor Drug Market Size Growth
5 Americas
5.1 Americas Anti-tumor Drug Market Size by Countries
5.2 Americas Anti-tumor Drug Market Size by Type
5.3 Americas Anti-tumor Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Anti-tumor Drug Market Size by Countries
6.2 APAC Anti-tumor Drug Market Size by Type
6.3 APAC Anti-tumor Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Anti-tumor Drug by Countries
7.2 Europe Anti-tumor Drug Market Size by Type
7.3 Europe Anti-tumor Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Anti-tumor Drug by Countries
8.2 Middle East & Africa Anti-tumor Drug Market Size by Type
8.3 Middle East & Africa Anti-tumor Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Anti-tumor Drug Market Forecast
10.1 Global Anti-tumor Drug Market Size Forecast (2018-2023)
10.2 Global Anti-tumor Drug Forecast by Regions
10.2.1 Global Anti-tumor Drug Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Anti-tumor Drug Forecast by Type
10.8 Global Anti-tumor Drug Forecast by Application
11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Anti-tumor Drug Product Offered
11.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 Novartis
11.2.1 Company Details
11.2.2 Anti-tumor Drug Product Offered
11.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Novartis News
11.3 Celgene
11.3.1 Company Details
11.3.2 Anti-tumor Drug Product Offered
11.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Celgene News
11.4 Bristol-Myers Squibb
11.4.1 Company Details
11.4.2 Anti-tumor Drug Product Offered
11.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Bristol-Myers Squibb News
11.5 Amgen
11.5.1 Company Details
11.5.2 Anti-tumor Drug Product Offered
11.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Amgen News
11.6 Johnson & Johnson
11.6.1 Company Details
11.6.2 Anti-tumor Drug Product Offered
11.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Johnson & Johnson News
11.7 Pfizer
11.7.1 Company Details
11.7.2 Anti-tumor Drug Product Offered
11.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Pfizer News
11.8 Takeda
11.8.1 Company Details
11.8.2 Anti-tumor Drug Product Offered
11.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Takeda News
11.9 Eli Lilly
11.9.1 Company Details
11.9.2 Anti-tumor Drug Product Offered
11.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Eli Lilly News
11.10 AstraZeneca
11.10.1 Company Details
11.10.2 Anti-tumor Drug Product Offered
11.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 AstraZeneca News
11.11 Astellas
11.12 Merck & Co
11.13 Sanofi
11.14 Bayer
11.15 Biogen Idec
11.16 Eisai
11.17 Teva
11.18 Otsuka
12 Research Findings and Conclusion
Table Product Specifications of Anti-tumor Drug
Figure Anti-tumor Drug Report Years Considered
Figure Market Research Methodology
Figure Global Anti-tumor Drug Market Size Growth Rate 2013-2023 ($ Millions)
Table Anti-tumor Drug Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Cytotoxic Drugs
Table Major Players of Non-cytotoxic Drugs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Global Cytotoxic Drugs Market Size Growth Rate
Figure Global Non-cytotoxic Drugs Market Size Growth Rate
Figure Anti-tumor Drug Consumed in Alkylating Agents
Figure Global Anti-tumor Drug Market: Alkylating Agents (2013-2018) ($ Millions)
Figure Global Alkylating Agents YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Anti-metabolism Drugs
Figure Global Anti-tumor Drug Market: Anti-metabolism Drugs (2013-2018) ($ Millions)
Figure Global Anti-metabolism Drugs YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Platinum Antineoplastic Agents
Figure Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2013-2018) ($ Millions)
Figure Global Platinum Antineoplastic Agents YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Anthracycline antitumor drugs
Figure Global Anti-tumor Drug Market: Anthracycline antitumor drugs (2013-2018) ($ Millions)
Figure Global Anthracycline antitumor drugs YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Microtubule Stabilizer
Figure Global Anti-tumor Drug Market: Microtubule Stabilizer (2013-2018) ($ Millions)
Figure Global Microtubule Stabilizer YoY Growth ($ Millions)
Table Global Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Global Anti-tumor Drug Market Size in Alkylating Agents Growth Rate
Figure Global Anti-tumor Drug Market Size in Anti-metabolism Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Platinum Antineoplastic Agents Growth Rate
Figure Global Anti-tumor Drug Market Size in Anthracycline antitumor drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Microtubule Stabilizer Growth Rate
Figure Global Anti-tumor Drug Market Size in Endocrine Therapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Immunotherapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Gene Therapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Targeted Antineoplastic Drugs Growth Rate
Table Global Anti-tumor Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Anti-tumor Drug Revenue Market Share by Players (2016-2018)
Figure Global Anti-tumor Drug Revenue Market Share by Players in 2017
Table Global Anti-tumor Drug Key Players Head office and Products Offered
Table Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Anti-tumor Drug Market Size by Regions 2013-2018 ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Regions 2013-2018
Figure Global Anti-tumor Drug Market Size Market Share by Regions 2013-2018
Figure Americas Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure APAC Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure Europe Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Table Americas Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Americas Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Type in 2017
Table Americas Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Application in 2017
Figure United States Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Canada Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table APAC Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Countries in 2017
Table APAC Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Type in 2017
Table APAC Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Application in 2017
Figure China Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Japan Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Korea Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure India Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Australia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table Europe Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Europe Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Type in 2017
Table Europe Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Application in 2017
Figure Germany Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure France Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure UK Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Italy Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Russia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Spain Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Middle East & Africa Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Type in 2017
Table Middle East & Africa Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Application in 2017
Figure Egypt Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Israel Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Global Anti-tumor Drug arket Size Forecast (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Regions
Figure Americas Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure APAC Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Europe Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure United States Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Canada Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Mexico Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Brazil Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure China Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Japan Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Korea Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure India Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Australia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Germany Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure France Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure UK Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Italy Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Russia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Spain Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Egypt Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure South Africa Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Israel Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Turkey Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure GCC Countries Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Table Global Anti-tumor Drug Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Type (2018-2023)
Table Global Anti-tumor Drug Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Application (2018-2023)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Roche Anti-tumor Drug Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Novartis Anti-tumor Drug Market Share (2016-2018)
Table Celgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celgene Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Celgene Anti-tumor Drug Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Anti-tumor Drug Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Amgen Anti-tumor Drug Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Anti-tumor Drug Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Pfizer Anti-tumor Drug Market Share (2016-2018)
Table Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table Takeda Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Takeda Anti-tumor Drug Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Anti-tumor Drug Market Share (2016-2018)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Anti-tumor Drug Market Share (2016-2018)
Table Astellas Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck & Co Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biogen Idec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table Otsuka Basic Information, Head Office, Major Market Areas and Its Competitors
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
